Establishment and characterization of a Fas-resistant T cell line

被引:1
|
作者
Higuchi, M
Horiuchi, T
Sawabe, T
Yoshizawa, S
Nagasawa, K
Niho, Y
机构
[1] Kyushu Univ, Fac Med, Dept Internal Med 1, Higashi Ku, Fukuoka 8128582, Japan
[2] Saga Med Sch, Dept Internal Med, Saga, Japan
关键词
apoptosis; ceramide; Fas; T cell;
D O I
10.1159/000040963
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Fas is a cell surface receptor that controls a signal transduction pathway leading to apoptosis. We established an antihuman Fas monoclonal antibody (mAb)-resistant variant, kit-225-FR, from the human T cell line, kit-225. Flow cytometric analysis revealed that the expression of Fas molecules on kit-225-FR was preserved, The defect in Fas molecule was not detected either by reverse transcription polymerase chain reaction (PCR) analysis of the Fas transcript or by PCR-single strand conformation polymorphism analysis of the Fas gene in kit-225-FR. Although kit-225-FR was resistant to a high concentration of anti-Fas-mAb, apoptosis could be induced, as with the wild type,by exogenous C2-ceramide exposure; MORT1/FADD was expressed at wild-type level in kit-225-FR, as determined by Western blot analysis. It therefore appears that the apoptotic signal transduction in kit-225-FR is defective between FADD and the sphingomyelin-ceramide pathway. By comparing the differences from the wild-type kit-225, kit-225-FR would serve as a useful cell line for analyzing Fas-specific signal transduction pathways in detail.
引用
收藏
页码:22 / 30
页数:9
相关论文
共 50 条
  • [1] Apoptosis in a Fas-resistant, T-cell receptor-sensitive human leukaemic T-cell clone
    Delehanty, LL
    Payne, JA
    Farrow, SN
    Brown, R
    Champion, BR
    [J]. IMMUNOLOGY, 1997, 90 (03) : 383 - 387
  • [2] Overexpression of mouse Fas receptor restores Fas-mediated apoptosis in HEP3B, a Fas-resistant hepatoma cell line.
    Lamboley, C
    Groyer, A
    Lardeux, B
    Bringuier, AF
    Feldmann, G
    [J]. HEPATOLOGY, 2000, 32 (04) : 495A - 495A
  • [3] Establishment and characterization of an abrin-resistant cell line
    Ko, JL
    Lin, JY
    [J]. CELL BIOLOGY AND TOXICOLOGY, 1997, 13 (02) : 75 - 81
  • [4] Establishment and characterization of an abrin-resistant cell line
    J.-L. Ko
    J.-Y. Lin
    [J]. Cell Biology and Toxicology, 1997, 13 : 75 - 81
  • [5] Lactacystin activates FLICE (caspase 8) protease and induces apoptosis in Fas-resistant adult T-cell leukemia cell lines
    Yamada, Y
    Sugahara, K
    Tsuruda, K
    Nohda, K
    Mori, N
    Hata, T
    Maeda, T
    Hayashibara, T
    Joh, T
    Honda, M
    Tawara, M
    Tomonaga, M
    Miyazaki, Y
    Kamihira, S
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2000, 64 (05) : 315 - 322
  • [6] Establishment of taxol-resistant KB cell line and its characterization
    Momotani, A
    Kumazawa, H
    Tachikawa, T
    Yamamoto, T
    Yamashita, T
    [J]. 1ST WORLD CONGRESS ON HEAD AND NECK ONCOLOGY, 1998, : 1071 - 1074
  • [7] Establishment and characterization of a cisplatin-resistant human neuroblastoma cell line
    Yasuno, T
    Matsumura, T
    Shikata, T
    Inazawa, J
    Sakabe, T
    Tsuchida, S
    Takahata, T
    Miyairi, S
    Naganuma, A
    Sawada, T
    [J]. ANTICANCER RESEARCH, 1999, 19 (5B) : 4049 - 4057
  • [8] Establishment and Characterization of a New Intrahepatic Cholangiocarcinoma Cell Line Resistant to Gemcitabine
    Varamo, Chiara
    Peraldo-Neia, Caterina
    Ostano, Paola
    Basirico, Marco
    Raggi, Chiara
    Bernabei, Paola
    Venesio, Tiziana
    Berrino, Enrico
    Aglietta, Massimo
    Leone, Francesco
    Cavalloni, Giuliana
    [J]. CANCERS, 2019, 11 (04):
  • [9] Establishment and characterization of an oxaliplatin-resistant hepatic cancer cell line
    Ping Qiu
    Gang Chen
    Yuhong Dai
    Hong Qiu
    [J]. Oncology and Translational Medicine, 2018, 4 (02) : 48 - 53
  • [10] Establishment and characterization of a cisplatin-resistant human osteosarcoma cell line
    Han, Tao
    Zhu, Xiaoming
    Wang, Julei
    Zhao, Haien
    Ma, Qiong
    Zhao, Jian
    Qiu, Xiuchun
    Fan, Qingyu
    [J]. ONCOLOGY REPORTS, 2014, 32 (03) : 1133 - 1139